Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell. 2013 Apr 15; 23(4):516-26.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Cross-Priming
HLA-A2 Antigen
HLA-D Antigens
Humans
Immunotherapy, Adoptive
Mice
Mice, Inbred C57BL
Mice, Transgenic
Neoplasms
Oligopeptides
Recurrence
T-Lymphocytes
Treatment Outcome
authors with profiles
Hans Schreiber
Stephen C. Meredith